跳至主要内容
临床试验/NCT04447456
NCT04447456已完成不适用

Comparison of Voice Results at 5 Years of Treatment of Glottic Squamous Cell Carcinoma T1 by Surgery Versus Radiotherapy

University Hospital, Lille2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2020年11月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
41
试验地点
2
主要终点
Voice Handicap Index

研究概览

简要总结

Patients with early-stage squamous cell carcinomas of the vocal cord can be treated in an equivalent way in terms of carcinology by surgery or radiotherapy. The study will be to analyse the vocal outcome at 5 years of these two types of management in order to define whether one is superior to the other on this criterion of voice quality after treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with glottic squamous cell carcinoma T1N0M0 who may benefit from treatment with exclusive radiotherapy or exclusive surgery.
  • •patients treated for these cancers at Lille University Hospital and the Oscar Lambret Centre between 2015 and
  • •Tis, T1a and T1b glottic squamous cell carcinomas according to the TNM 7th edition classification in long-term survivors.

排除标准

  • 未提供

研究组 & 干预措施

Surgery

Radiotherapy

结局指标

主要结局

Voice Handicap Index

时间窗: At 5 years

The VHI is a self-administered questionnaire that provides a score ranging from 0 to 120 points validated in France and internationally based on the declarative answers to 30 items of the questionnaire. A high score corresponds to a voice felt to be of poor quality. This is a subjective assessment made by the patient.

次要结局

  • Maximum Phonation Time(At 5 years)
  • Grade, Roughness, Breathiness, Asthenia, Strain, Instability SCORE (GRBASI Score)(At 5 years)
  • Acoustic Analysis by Vocalab software(At 5 years)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验